Clinical Trial Update: Donafenib for Previously Treated Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for donafenib in previously treated metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Donafenib (donafenib)

Snippet

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Conditions: Metastatic Colorectal Cancer | Phase 3 | Status: COMPLETED